| Authors: |
Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: andrea.apolo@nih.gov., Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free National Health Service Trust, London, UK., Escudier B; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile., Zhang J; Department of Clinical Research, Bristol Myers Squibb, Princeton, NJ, USA., Simsek B; Department of Global Biometrics and Data Science, Bristol Myers Squibb, Princeton, NJ, USA., Scheffold C; Department of Clinical Development, Exelixis, Alameda, CA, USA., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Choueiri TK; Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA. |
